Contents

Search

meningoccal conjugate vaccine ACWY (Menveo)

different vaccines for different serotypes Indications: - prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135 - routine use in adolescents age 11- 12 years, with a booster at 16 years - immunosuppressed* persons age 2-54 years - 1st dose administered after age 16 years a booster is not required - college freshmen living in resident halls should receive the vaccine within 5 years of enrollment - all patients with HIV1 disease - 2 dose schedule for patients > 2 years of age plus booster doses every 5 years [4] * patients with terminal complement deficiency are at higher risk for meningococcal disease - patients with immunoglobulin deficiency are not [2] Notes: - sometimes improperly prepared and administered by providers [1]

Related

Neisseria meningitidis (meningococcus)

Specific

meningococcal polysaccharide vaccine (Menomune-A/C/Y/W-135, MenACWY-CRM, Menactra, MenACYW-D)

General

meningococcal vaccine

References

  1. Su JR, Miller ER, Duffy J et al Notes from the Field: Administration Error Involving a Meningococcal Conjugate Vaccine- United States, March 1, 2010- September 22, 2015. MMWR Weekly / February 19, 2016 / 65(6);161-162 http://www.cdc.gov/mmwr/volumes/65/wr/mm6506a4.htm
  2. Medical Knowledge Self Assessment Program (MKSAP) 17, American College of Physicians, Philadelphia 2015
  3. Cohn AC, MacNeil JR, Clark TA et al for the Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 Mar 22;62(RR-2):1-28. PMID: 23515099 Free Article
  4. MacNeil JR, Rubin LG, Patton M, Ortega-Sanchez IR, Martin SW. Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons - Advisory Committee on Immunization Practices, 2016. MMWR Morb Mortal Wkly Rep 2016;65:1189-1194 https://www.cdc.gov/mmwr/volumes/65/wr/mm6543a3.htm

Component-of

Haemophilus b Conjugate Vaccine - Meningococcal Protein Conjugate (Hib-MenCY-TT) haemophilus b conjugate vaccine meningococcal protein conjugate